Loeb et al. [28] revealed the patients with a bGS of 6 (Grade Group 1), PSA between 10 and 15 mg/ml and a PSA density less than 0.15 ng/ml did not significantly differ in adverse pathology findings when compared to those with LR PCa. The gene discussed is KLK3; the disease is posterior cortical atrophy.